Dr Lavarez Dell Harris, EDD, LMFT, CLC | |
26641 W Matthew Dr, Buckeye, AZ 85396-8011 | |
(949) 275-4499 | |
Not Available |
Full Name | Dr Lavarez Dell Harris |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 26641 W Matthew Dr, Buckeye, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093313850 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 15383 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Lavarez Dell Harris, EDD, LMFT, CLC 16772 W Bell Rd Ste 110-284, Surprise, AZ 85374-9702 Ph: (949) 677-9740 | Dr Lavarez Dell Harris, EDD, LMFT, CLC 26641 W Matthew Dr, Buckeye, AZ 85396-8011 Ph: (949) 275-4499 |
News Archive
The Mass Adult Day Health Alliance, the largest provider of adult day health programs for elders in Massachusetts, announced today that it has been acquired by Civitis Solutions Inc., a national organization of local health and human services providers that markets its services under the name The MENTOR Network.
Pregnant non-smokers who breathe in the second-hand smoke of other people are at an increased risk of delivering stillborn babies or babies with defects, a study led by researchers at The University of Nottingham has found.
On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein (non-HDL) cholesterol in patients with homozygous familial hypercholesterolemia (HoFH). Juxtapid is intended for use in combination with a low fat diet and other lipid-lowering treatments.
Your baby, who used to play so nicely, suddenly seems less attentive and appears to have difficulty concentrating.
CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.
› Verified 7 days ago
Liana Lucille Hoover, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 20882 W Eastview Way, Buckeye, AZ 85396 Phone: 623-248-1704 | |
Mrs. Rachel Lee Bentley, M.A. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1300 N Miller Rd, Buckeye, AZ 85326 Phone: 623-236-3685 |